← FDA Drug Approvals (Drugs@FDA)
BIVALIRUDIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SHUANGCHENG · Approved 2019-10-23
Drug application
- FDA Application #
ANDA210031- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BIVALIRUDIN
- Generic name
- BIVALIRUDIN
- Active ingredients
- BIVALIRUDIN
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- SHUANGCHENG
- Manufacturer
- Avenacy, Inc.
- First approval
- 2019-10-23
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown